Clinical Trial Search

Primary: Number of Participants Who Achieved Clinical Resolution at Visit 3 — 127; 123 Participants

Primary: Participants Who Achieved Clinical Resolution — 82; 74 Participants

Primary: Sputum Glucose Concentration — 68.92; 12.2 µM

Primary: Change From Baseline in Ocular Itching at 14 Days — 2.17; 1.82 units on a scale

Primary: Total Number of Participants With Negative Chlamydia Direct Fluorescent Antibody (DFA) Test Results After Oral Azithromycin Treatments — 27 participants

Primary: Change From Baseline Bacterial Culture — 30; 16; 26; 29 cultures — p=0.002

Primary: Clinical Cure Rate — 85.4; 81.4 percentage of participants

Primary: Susceptability Changes in Streptococcus Pneumoniae Distal to the Site of Instillation — 0; 0; 0; 0 Percent of resistant isolates

Primary: Exploratory Outcomes From Digital Photography — 17; 7 Participants

Primary: Percentage of Patients With Clearing (Clinical Success) of Conjunctival Hyperemia and Conjunctival Discharge Up to Day 6 — 51.8; 41.3 Percentage of Patients

Primary: The Primary Efficacy Variable Was Clinical Cure in the Worse Eye on Day 3 — 48; 29 participants

Primary: Clinical Resolution of Baseline Bacterial Conjunctivitis (Day 8 or 9) — 37; 20 Participants

Primary: Clinical Cure Rate — 37; 31; 27; 33 Participants — p=0.0137

Primary: Clinical Cure at the Day 4 (EOT)/Exit Visit — 62.5; 50.6 percentage of subjects

Primary: Clinical Resolution — 89; 62 eyes